Delivery Order SPE2DB24D2205-SPE2DB25FEFSQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,709.46 to AmerisourceBergen Drug Corp for supply of Dupixent 300 mg/2 ml pen (2 ml) with a firm fixed price contract type. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025, and no set-aside designation was applied. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $14,934.34 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $109,981.33 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Dupixent 300 mg/2 mL pens. This firm fixed-price contract, with an ultimate completion date of September 16, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The award was competitively awarded with no set-aside designation,...
- The Defense Logistics Agency awarded a $3,877.08 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen medications on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a $3,418.92 delivery order to AmerisourceBergen Drug Corp on June 23, 2025, for the supply of Dupixent 200 mg/1.14 mL pen injectors. This is a firm fixed price, non-set-aside contract with an ultimate completion date of June 24, 2025, and performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $9,133.25 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dupixent 300 mg/2 ml pen injections. This is a firm fixed price delivery order with an ultimate completion date of July 29, 2025, representing a short-duration pharmaceutical supply contract. The award carries no set-aside designation, indicating it was competitively awarded through open procurement processes. AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $11,417.87 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen (2 ml) on August 29, 2025, with an ultimate completion date of September 2, 2025. This is a firm fixed price, non-set-aside contract with place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Dupixent 300 mg/2 mL pens with a ceiling value of $5,128.38. This firm fixed-price, non-set-aside contract is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999 and extends through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $6,238.00 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Dupixent 300 mg/2 mL pens (2 mL quantity). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be performed at the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of June 2, 2025. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,340.32 on September 9, 2025, for the supply of Dupixent 300 mg/2 mL pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFSQDelivery Order
The Defense Logistics Agency awarded a $25,186.62 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens (2 mL) under a firm fixed price contract type. The award was issued on August 1, 2025, with an ultimate completion date of August 4, 2025, and no set-aside designation was applied. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999.999 billion ceiling and runs through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical supply needs for the federal government, particularly supporting military and veteran healthcare systems. The company's comprehensive federal contract portfolio demonstrates extensive experience delivering a wide range of pharmaceutical products, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order for Dupixent, a prescription medication used to treat certain inflammatory conditions, reflects AmerisourceBergen's role as a primary pharmaceutical vendor for the Defense Health Agency and other federal healthcare programs through the DLA's competitive, non-set-aside procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.2k | 8/1/25 |